EUIPO trademark

GENEACT

RegisteredEUIPOWord markClass 42Class 44

"GENEACT" is a word mark owned by Alnylam Pharmaceuticals, Inc., filed at the EUIPO on June 20, 2024. It is registered and covers classes 42 and 44.

View Alnylam Pharmaceuticals, Inc. portfolioGet this data via the API
Official EUIPO record
GENEACT
Word mark as filed with the EUIPO
Status
Registered
Since October 15, 2024
Filed
June 20, 2024
Registered
October 12, 2024
Expires
June 20, 2034
Application no.
019043992
Registration no.
019043992
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
2 classes
Ownership

Who owns GENEACT

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Alnylam Pharmaceuticals, Inc.

ALNY

69 trademarks in the portfolioView company

Representative

Areopage

Goods and services

What the mark covers

The products and services GENEACT is filed for, grouped by Nice class.

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2024/198 Section B.1
  2. Bulletin 2024/126 Section A.1
FAQ

About GENEACT

Who owns the trademark "GENEACT"?

The EUIPO trademark "GENEACT" (application 019043992) is owned by Alnylam Pharmaceuticals, Inc.

What is the status of "GENEACT"?

Its status at the EUIPO is: registered.

When was "GENEACT" registered?

It was registered on October 12, 2024 and is due to expire on June 20, 2034.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull GENEACT and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d45d5-c1a3-7698-ad74-c700825c634a
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d45d5-c1a3-7698-ad74-c700825c634a",
  "object": "trademark",
  "mark_text": "GENEACT",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "019043992",
  "filing_date": "2024-06-20",
  "nice_classes": [
    42,
    44
  ],
  "owners": [
    {
      "name": "Alnylam Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb709-7d9a-70dc-b19d-2c56e8a223b5"
    }
  ]
}